Search

everythinglearnresearchcommunity

for

Search:↓

Immune therapy for cancer can cause hair loss scars in some patients.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Most patients with dermatomyositis had skin rash and were treated with prednisolone and hydroxychloroquine.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

People with Down syndrome have higher rates of certain immune-related conditions and need special medical attention.

Immunological treatment improved both neuropathy and alopecia.

A 12-year-old boy had severe shingles and skin damage after a stem-cell transplant.

Skin fungal infections are more common in older adults due to factors like obesity, poor circulation, reduced mobility, and weakened immune defenses from certain medications.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Alopecia is rare after organ transplants but more common in females, Hispanic patients, and pancreas recipients.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Trichodysplasia spinulosa is a rare skin disease in immunocompromised patients caused by a specific virus targeting hair follicle cells.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Infections during JAK inhibitor treatment for alopecia areata are usually manageable and rarely stop treatment permanently.

Cyclosporine A treatment caused rare hair repigmentation in a 65-year-old man.